{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:12:25Z","timestamp":1790017945004,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Landesgraduiertenf\u00f6rderung Programme of the State of Baden-W\u00fcrttemberg"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jagp.2016.07.024","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T12:03:25Z","timestamp":1470398605000},"page":"1182-1188","source":"Crossref","is-referenced-by-count":16,"title":["Limitations of the Anticholinergic Activity Assay and Assay-Based Anticholinergic Drug Scales"],"prefix":"10.1016","volume":"24","author":[{"given":"Tanja","family":"Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Kopitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstanze","family":"Plaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna M.","family":"Seidling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Haefeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2016.07.024_bib0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1517\/14740338.2011.579899","article-title":"Drugs with anticholinergic properties: a current perspective on use and safety","volume":"10","author":"Gerretsen","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jagp.2016.07.024_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archpsyc.1980.01780160063007","article-title":"Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects","volume":"37","author":"Tune","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2016.07.024_bib0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","article-title":"Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study","volume":"332","author":"Ancelin","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2016.07.024_bib0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2012-110935","article-title":"Anticholinergic drugs in late life: adverse effects on cognition but not on progress to dementia","volume":"30","author":"Whalley","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2016.07.024_bib0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000325171","article-title":"Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study","volume":"31","author":"Sittironnarit","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jagp.2016.07.024_bib0035","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","article-title":"Anticholinergic activity of 107 medications commonly used by older adults","volume":"56","author":"Chew","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2016.07.024_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2007.02.015","article-title":"Significant correlation between plasma and CSF anticholinergic activity in presurgical patients","volume":"417","author":"Plaschke","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jagp.2016.07.024_bib0045","first-page":"225","article-title":"The cognitive impact of anticholinergics: a clinical review","volume":"4","author":"Campbell","year":"2009","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jagp.2016.07.024_bib0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2202-9-86","article-title":"Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium","volume":"9","author":"Thomas","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.jagp.2016.07.024_bib0055","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00228-015-1932-x","article-title":"Different methods, different results\u2014how do available methods link a patient's anticholinergic load with adverse outcomes?","volume":"71","author":"Mayer","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jagp.2016.07.024_bib0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jagp.2016.07.024_bib0065","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00192-005-0058-6","article-title":"Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin","volume":"17","author":"Cardozo","year":"2006","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.jagp.2016.07.024_bib0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2007.05.004","article-title":"Pharmacology of N-desmethylclozapine","volume":"115","author":"Lameh","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jagp.2016.07.024_bib0075","series-title":"GraphPad Prism [computer program]","year":"2016"},{"key":"10.1016\/j.jagp.2016.07.024_bib0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application","volume":"4","author":"Boustani","year":"2008","journal-title":"Aging Health"},{"key":"10.1016\/j.jagp.2016.07.024_bib0085","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","article-title":"The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity","volume":"46","author":"Carnahan","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jagp.2016.07.024_bib0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.clpt.6100435","article-title":"Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease","volume":"84","author":"Cancelli","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jagp.2016.07.024_bib0095","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.161.8.1099","article-title":"Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients","volume":"161","author":"Han","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jagp.2016.07.024_bib0100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jagp.2016.07.024_bib0105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jagp.2016.07.024_bib0110","series-title":"QuickCalcs [computer program]","year":"2016"},{"key":"10.1016\/j.jagp.2016.07.024_bib0115","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","article-title":"Systematic review of anticholinergic risk scales in older adults","volume":"69","author":"Dur\u00e1n","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jagp.2016.07.024_bib0120","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","article-title":"N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity","volume":"33","author":"Jensen","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jagp.2016.07.024_bib0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/gerona\/gls176","article-title":"Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial","volume":"68","author":"Kersten","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jagp.2016.07.024_bib0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jamda.2014.05.004","article-title":"Cognitive deficit reversal as shown by changes in the Veterans Affairs Saint Louis University Mental Status (SLUMS) examination scores 7.5 years later","volume":"15","author":"Cruz-Oliver","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jagp.2016.07.024_bib0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0300-9432(74)90101-0","article-title":"Distribution of amitriptyline and nortriptyline in fatal amitriptyline intoxications with different survival times","volume":"4","author":"Norheim","year":"1974","journal-title":"Forensic Sci"},{"key":"10.1016\/j.jagp.2016.07.024_bib0140","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/10665270260518317","article-title":"Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms","volume":"9","author":"Doniger","year":"2002","journal-title":"J Comput Biol"},{"key":"10.1016\/j.jagp.2016.07.024_bib0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00007611-198303000-00020","article-title":"Systemic effects of topical ophthalmic medications","volume":"76","author":"Selvin","year":"1983","journal-title":"South Med J"},{"key":"10.1016\/j.jagp.2016.07.024_bib0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0893-133X(98)00048-7","article-title":"Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells","volume":"20","author":"Olianas","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jagp.2016.07.024_bib0155","series-title":"A Pharmacology Primer: Theory, Applications, and Methods","author":"Kenakin","year":"2009"},{"key":"10.1016\/j.jagp.2016.07.024_bib0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1254\/jphs.09013FP","article-title":"Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression","volume":"110","author":"Vezmar","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jagp.2016.07.024_bib0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/j.1552-4604.1990.tb01871.x","article-title":"Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children","volume":"30","author":"Simons","year":"1990","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jagp.2016.07.024_bib0170","first-page":"83","article-title":"Determination of bioequivalence of two furosemide preparations; the effect of high doses of furosemide on some pharmacokinetic parameters","volume":"16","author":"Wolf-Coporda","year":"1996","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.jagp.2016.07.024_bib0175","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","article-title":"Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database","volume":"31","author":"Reis","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jagp.2016.07.024_bib0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0928-0987(98)00054-2","article-title":"A pilot study of the disposition of pilocarpine in plasma, saliva and urine after a single oral dose","volume":"8","author":"Aromdee","year":"1999","journal-title":"Eur J Pharm Sci"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748116302020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748116302020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T06:57:04Z","timestamp":1568271424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748116302020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1064748116302020"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2016.07.024","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}